New PCR test for Rickettsia infection diagnosis
Part of Infections clinical trials.
This trial is testing a new PCR test to diagnose Rickettsia infections more quickly. It may help if you have a skin lesion called an eschar or if your doctor has ordered a blood test for Rickettsia antibodies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a dark scab-like skin lesion (eschar)
- Your doctor has requested a test for Rickettsia antibodies
- You are willing to provide a sample for the new test
- You are not excluded for any reason
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
This trial uses stored samples to see if a newer test (PCR) is as good as standard tests at detecting three infections: Pneumocystis (a lung infection), malaria, and leishmaniasis. It does not involve new treatments.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This study is for anyone 8 or older in an area of northern Italy where tick diseases are common. If you need a tick removed, researchers want to test the tick to learn more about tick-borne illnesses and how to prevent them.
This study is tracking patients with a suspected or confirmed rickettsiosis infection, which is a bacterial disease spread by ticks. It aims to see how the illness progresses and how it is treated.
This study tests antibiotics to help your body clear rickettsia-related illnesses like murine typhus or scrub typhus. It may help reduce symptoms and shorten how long you feel sick, based on how well the infection clears.
Hear when a new Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.